Blog

Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM

Photo collage of Rahul Banerjee & Hang Quach

Jul 9, 2024, 06:35

Rahul Banerjee: Nice analysis of Australia/New Zealand multiple myeloma with emphasis on CRAB vs SLiM

Rahul Banerjee, Assistant Professor at UW Medicine, made the following post on X:

“Now in The British Journal of Haematology – nice analysis of Australia/New Zealand multiple myeloma patients by Hang Quach et al, emphasis on CRAB vs SLiM-presenting myeloma.

PFS better with SLiM-only as expected, but PFS2 and OS also better: less resistant relapses when clones treated at earlier stages?”

Read further.
Source: Rahul Banerjee/X

Australia British Journal of Haematology cancer Cancer research CRAB criteria Hang Quach Hematology multiple myeloma New Zealand OncoDaily Oncology OS PFS Rahul Banerjee Research SLiM criteria UW Medicine

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage